UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 7, 2015

 


 

PHYSICIANS REALTY TRUST

(Exact name of registrant as specified in its charter)

 


 

Maryland
(State or other jurisdiction of
incorporation or organization)

 

001-36007
(Commission File Number)

 

46-2519850
(I.R.S. Employer Identification No.)

 

735 N. Water Street, Suite 1000

Milwaukee, Wisconsin
(Address of principal executive offices)

 

53202
(Zip Code)

 

Registrant’s telephone number, including area code: (414) 978-6494

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 5.07                                  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

On May 7, 2015, Physicians Realty Trust (the “Company”) held the 2015 Annual Meeting of Shareholders in Milwaukee, Wisconsin (the “Annual Meeting”). At the Annual Meeting, the shareholders of the Company considered and voted on three proposals submitted for shareholder vote, each of which is more fully described in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on March 25, 2015 (the “Proxy Statement”). The following is a brief description of the matters voted on at the Annual Meeting and the final results of such voting.

 

PROPOSAL ONE.                                        Election of Trustees. The individuals listed below were elected to the Board of Trustees of the Company, each of whom will serve until the next annual meeting of shareholders and until his respective successor is duly elected and qualified:

 

 

 

For

 

Withheld

 

Abstained

 

Broker Non-votes

 

John T. Thomas

 

49,800,454

 

4,795,267

 

 

9,693,019

 

Tommy G. Thompson

 

47,462,363

 

7,133,358

 

 

9,693,019

 

Stanton D. Anderson

 

52,324,116

 

2,271,605

 

 

9,693,019

 

Mark A. Baumgartner

 

46,254,714

 

8,341,007

 

 

9,693,019

 

Albert C. Black, Jr.

 

52,257,045

 

2,338,676

 

 

9,693,019

 

William A. Ebinger, M.D.

 

53,430,495

 

1,165,226

 

 

9,693,019

 

Richard A. Weiss

 

30,720,112

 

23,875,609

 

 

9,693,019

 

 

PROPOSAL TWO.                                    Ratification of Independent Registered Public Accounting Firm. A proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2015 was approved as follows:

 

For

 

Against

 

Abstained

 

Broker Non-votes

 

63,818,199

 

427,550

 

42,991

 

 

 

PROPOSAL THREE.                      Approval of Physicians Realty Trust 2015 Employee Stock Purchase Plan. A proposal to approve the Physicians Realty Trust 2015 Employee Stock Purchase Plan, a description of which is contained in the Proxy Statement, was approved as follows:

 

For

 

Against

 

Abstained

 

Broker Non-votes

 

53,968,297

 

449,268

 

178,156

 

9,693,019

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: May 7, 2015

PHYSICIANS REALTY TRUST

 

 

 

By:

/s/ John T. Thomas

 

 

John T. Thomas

 

 

President and Chief Executive Officer

 

3